MDT

98.12

+1.73%↑

A

146.22

-0.4%↓

VEEV

218.31

-4.16%↓

HQY

85.42

+3.09%↑

PHR.US

16.15

-2.24%↓

MDT

98.12

+1.73%↑

A

146.22

-0.4%↓

VEEV

218.31

-4.16%↓

HQY

85.42

+3.09%↑

PHR.US

16.15

-2.24%↓

MDT

98.12

+1.73%↑

A

146.22

-0.4%↓

VEEV

218.31

-4.16%↓

HQY

85.42

+3.09%↑

PHR.US

16.15

-2.24%↓

MDT

98.12

+1.73%↑

A

146.22

-0.4%↓

VEEV

218.31

-4.16%↓

HQY

85.42

+3.09%↑

PHR.US

16.15

-2.24%↓

MDT

98.12

+1.73%↑

A

146.22

-0.4%↓

VEEV

218.31

-4.16%↓

HQY

85.42

+3.09%↑

PHR.US

16.15

-2.24%↓

Search

Palvella Therapeutics Inc

Open

SectorHealthcare

102.14 0.78

Overview

Share price change

24h

Current

Min

99.79

Max

103.73

Key metrics

By Trading Economics

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+81.31% upside

Dividends

By Dow Jones

Next Earnings

30 Mar 2026

News Sentiment

By Acuity

50%

50%

183 / 361 Healthcare

Palvella Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

13 Jan 2026, 19:05 UTC

Major Market Movers

Travere Therapeutics Shares Fall After FDA Extends Filspari Review

13 Jan 2026, 23:41 UTC

Market Talk

Nikkei May Rise on Japan Election Hopes -- Market Talk

13 Jan 2026, 23:41 UTC

Market Talk

Global Equities Roundup: Market Talk

13 Jan 2026, 23:33 UTC

Market Talk

Gold Edges Higher, Supported by Ongoing Geopolitical Tensions -- Market Talk

13 Jan 2026, 23:13 UTC

Acquisitions, Mergers, Takeovers

JD Logistics Plans to Withdraw Listing Status of Deppon Logistics From Shanghai Stock Exchange

13 Jan 2026, 23:10 UTC

Acquisitions, Mergers, Takeovers

JD Logistics Makes Cash Offer to Buy Deppon Logistics Shares It Doesn't Already Own

13 Jan 2026, 23:03 UTC

Market Talk

Woodside's Sales Revenue Likely Fell 13% in 4Q -- Market Talk

13 Jan 2026, 21:50 UTC

Acquisitions, Mergers, Takeovers

Netflix Preparing to Make Warner Bid All-Cash -- WSJ

13 Jan 2026, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Basic Materials Roundup: Market Talk

13 Jan 2026, 21:20 UTC

Acquisitions, Mergers, Takeovers

Versant Media: Katz Will Continue to Lead Day-To-Day Ops of FTN

13 Jan 2026, 21:20 UTC

Acquisitions, Mergers, Takeovers

Versant Media: Transaction Strengthens Distribution Footprint and Expands Free-To-Watch Portfolio >VSNT

13 Jan 2026, 21:20 UTC

Acquisitions, Mergers, Takeovers

Versant Media: Jonathan Katz, FTN's Founder, Has Joined VERSANT, Reporting to David Pietrycha >VSNT

13 Jan 2026, 21:15 UTC

Acquisitions, Mergers, Takeovers

VERSANT Completes Acquisition Of Free TV Networks >VSNT

13 Jan 2026, 21:08 UTC

Acquisitions, Mergers, Takeovers

Array Digital Infrastructure Declares Special Dividend of $10.25 >AD

13 Jan 2026, 20:39 UTC

Market Talk

Silver Settles at Another New High -- Market Talk

13 Jan 2026, 20:21 UTC

Market Talk

Oil Futures Extend Rally On Rising Iran Tensions -- Market Talk

13 Jan 2026, 20:17 UTC

Market Talk

U.S. Natural Gas Edges Up on Coming Weather -- Market Talk

13 Jan 2026, 19:08 UTC

Acquisitions, Mergers, Takeovers

Super Micro Computer Is an AI Winner. Sell the Stock Anyway, Goldman Sachs Says. -- Barrons.com

13 Jan 2026, 19:03 UTC

Earnings

Double-Digit Earnings Growth Could Continue. It Still Might Not Satisfy Investors. -- Barrons.com

13 Jan 2026, 18:50 UTC

Earnings

JPMorgan's Unusual Quarter Weighs on Shares. How Apple Plays a Role. -- Barrons.com

13 Jan 2026, 17:54 UTC

Market Talk

UnitedHealth Reaffirms 2025 Guidance After Senate Report -- Market Talk

13 Jan 2026, 17:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Global Equities Roundup: Market Talk

13 Jan 2026, 17:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Netflix Will Be a Winner No Matter How Warner Saga Ends -- Market Talk

13 Jan 2026, 17:49 UTC

Market Talk

Analysts Call For Potential Record Ethanol Output -- Market Talk

13 Jan 2026, 17:38 UTC

Market Talk

Merck CEO Sees $5B Market for Cidara's Flu Antiviral -- Market Talk

13 Jan 2026, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

13 Jan 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

13 Jan 2026, 17:20 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Basic Materials Roundup: Market Talk

13 Jan 2026, 17:19 UTC

Market Talk

Credit Cards Present Opportunity, Potential Obstacle for JPMorgan -- Market Talk

13 Jan 2026, 17:15 UTC

Market Talk

Merck CEO Sees Eventual Growth After Keytruda Exclusivity Expires -- Market Talk

Peer Comparison

Price change

Palvella Therapeutics Inc Forecast

Price Target

By TipRanks

81.31% upside

12 Months Forecast

Average 182.2 USD  81.31%

High 212 USD

Low 133 USD

Based on 15 Wall Street analysts offering 12 month price targets forPalvella Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

15 ratings

15

Buy

0

Hold

0

Sell

Sentiment

By Acuity

183 / 361 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

$

help-icon Live chat